In vivo paracrine interaction between urokinase and its receptor: Effect on tumor cell invasion

Journal of Cell Biology

Volumn 115, Issue 4, 1991, Pages 1107-1112

  Ossowski, Liliana ^a   Clunie, Garfield ^a   Masucci, Maria Teresa ^b,c   Blasi, Francesco ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; UROKINASE;

ANIMAL CELL; ARTICLE; CELL INVASION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMAL; CELL COMMUNICATION; CHICK EMBRYO; DISEASE MODELS, ANIMAL; HUMAN; KINETICS; MICE; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0026341460     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.115.4.1107     Document Type: Article

References (48)

1. Appella, E., E. A. Robinson, S. J. Ulrich, M. P. Stopelli, A. Corti, G. Cassani, and F. Blasi. 1987. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J. Biol. Chem. 262:4437-4440.
2. Axelrod, J. H., R. Reich, and R. Miskin. 1989. Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells. Mol. Cell. Biol. 9:2133-2141.
3. Basset, P., J. P. Bellocq, C. Wolf, I. Stol, P. Hutin, J. M. Limacher, O. L. Podhajcer, M. P. Chenard, M. C. Rio, and P. Chambon. 1990. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.). 348:699-704.
4. Camps, J. L., S.-M. Chang, T. C. Hsu, M. R. Freeman, S.-J. Hong, H. E. Zhau, A. C. von Eschenbach, and L. W. K. Chung. 1990. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl. Acad. Sci. USA. 87:75-79.
5. Chapman, H. A., Z. Vavrin, and J. B. Hibbs. 1982. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator. Cell. 28:653-662.
6. Chiquet Ehrismann, R., P. Kella, and C. A. Pearson. 1989. Participation of tenascin and TGF-beta in reciprocal epithelial-mesenchymal interaction of MCF-7 cells and fibroblasts. Cancer Res. 49:4322-4325.
7. Cubellis, M. V., M. L. Nolli, G. Cassani, and F. Blasi. 1986. Binding of single chain prourokinase to the urokinase receptor of human U937 cells. J. Biol. Chem. 261:15819-15822.
8. Dano, K., P. A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139-266.
9. Deutsch, D. G., and E. T. Mertz. 1970. Plasminogen purification from human plasma by affinity chromatography. Science (Wash. DC). 170:1095-1096.
10. Duffy, M. J., and P. O'Grady. 1984. Plasminogen activator and cancer. Eur. J. Cancer Clin. Oncol. 20:577-582.
11. Estreicher, A., A. Wohlwend, D. Belin, W.-D. Schleuning, and J.-D. Vassalli. 1989. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem. 264:1180-1189.
12. Granelli-Piperno, A., and E. Reich. 1978. A study of protease-inhibitor complexes in biological fluids. J. Exp. Med. 148:223-234.
13. He, C., S. M. Wilhelm, A. P. Pentland, B. L. Manner, G. A. Grant, A. Z. Eisen, and G. I. Goldberg. 1989. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA. 86:2632-2636.
14. Janicke, F., M. Schmitt, R. Harter, A. Hollrieder, R. Babic, K. Ulm, W. Gossner, and H. Graeff. 1990. Urokinase-type plasminogen activator (uPA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis. 4:69-78.
15. Jones, P., and Y. A. DeClerck. 1980. Destruction of extracellular matrices containing glycoproteins, elastin and collagen by metastatic human tumor cells. Cancer Res. 40:3222-3227.
16. Kerbel, R. 1990. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv. Cancer Res. 55:87-130.
17. Liotta, L., and W. Stetler-Stevenson. 1989. Metalloproteinases and malignant conversion: does correlation imply causality? J. Natl. Cancer Inst. 81:556-557.
18. Markus, G. 1988. The relevance of plasminogen activators to neoplastic growth. A review of recent literature. Enzyme. 40:158-172.
19. Mignatti, P., E. Robbins, and D. B. Rifkin. 1986. Tumor invasion through the human amniotic membrane; Requirement for a proteinase cascade. Cell. 47:487-498.
20. Mira y Lopez, R., and L. Ossowski. 1987. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness. Cancer Res. 47:3558-3564.
21. Mullins, D. E., and S. T. Rohrlich. 1983. The role of proteinases in cellular invasiveness. Biochim Biophys. Acta. 695:177-214.
22. Nielsen, L. S., J. G. Hansen, L. Skriver, E. L. Wilson, K. Kaltoft, J. Zeuthen, and K. Dano. 1982. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry. 24:6410-6415.
23. Nolli, M. L., E. Sarubbi, A. Corti, F. Robbiati, A. Soffientini, F. Blasi, F. Parenti, and G. Cassani. 1989. Production and characterization of human recombinant single chain urokinase-type plasminogen activator from mouse cells. Fibrinolysis. 3:101-106.
24. Ossowski, L. 1988a. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell-surface bound urokinase. J. Cell Biol. 107:2437-2445.
25. Ossowski, L. 1988b. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell. 52:321-328.
26. Ossowski, L., and E. Reich. 1983. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell. 35:611-619.
27. Ossowski, L., H. Russo-Payne, and E. L. Wilson. 1991. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res. 51:274-281.
28. Paranjpe, M., L. Engel, N. Young, and L. Liotta. 1980. Activation of human breast carcinoma collagenase through plasminogen activator. Life Sci. 26:1223-1231.
29. Plow, E. F., D. E. Freaney, J. Plescia, and L. A. Miles. 1986. The plasminogen activator system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol. 103:2411-2420.
30. Pyke, C., P. Kristensen, E. Ralfkiaer, J. Grondahl-Hansen, J. Eriksen, and K. Dano. 1991. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Pathol. 138:1059-1067.
31. Quax, P., N. Padersen, M.-T. Masucci, J. Weening-Verhoeff, K. Dano, J. Verheijen, and F. Blasi. 1991. Complementation analysis of extracellular matrix degradation: enhancement of urokinase plasminogen activation by the urokinase receptor. Cell Reg. In press.
32. Quigley, J. P. 1976. Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells. J. Cell Biol. 71:472-476.
33. Rand Pritchett, T., J. K. M. Wang, and P. A. Jones. 1989. Mesenchymal-epithelial interactions between normal and transformed tumor cells. Cancer Res. 49:2750-2754.
34. Reich, R. Activation of plasminogen: a general mechanism for producing localized extracellular proteolysis. In Molecular Basis for Biological Reproductive Processes. R. D. Berlin, Herman. M., Lepow, I. H., and J. M. Tanzer editors. Academic Press, New York. 155-169.
35. Roldan, A., M. V. Cubellis, M. T. Masucci, N. Behrendt, L. R. Lund, K. Dano, E. Appella, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell-surface plasmin-dependent proteolysis. EMBO (Eur. Mol. Biol. Organ.) J. 9:467-474.
36. Saksela, O., and D. B. Rifkin. 1988. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4:93-126.
37. Sas, D. F., J. B. McCarthy, and L. T. Furcht. 1986. Clearing and release of basement proteins from substrates by metastatic tumor cell variants. Cancer Res. 46:3082-3089.
38. Schlechte, W., G. Murano, and D. Boyd. 1989. Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation. Cancer Res. 49:6064-6069.
39. Sloan, B. F., Robinson, D., and K. D. Honn. 1990. Role for cathepsin B and cystatins in tumor growth and progression. Biol. Chem. Hoppe Seyler (Suppl). 371:193-198.
40. Stoppelli, M. P., A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R. K. Assoian. 1985. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci USA. 82:4939-4943.
41. Testa, J. E., and J. P. Quigley. 1990. The role of plasminogen activator in aggressive tumor behavior. Cancer Metastasis Rev. 9:353-367.
42. Unkeless, J. C., A. Tobia, L. Ossowski, J. P. Quigley, D. B. Rifkin, and E. Reich. 1973. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. J. Exp. Med. 137:85-111.
43. r 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100:86-92.
44. Verheijen, J. H., E. Mullaart, G. T. G. Chang, C. Kluft, and G. Wijngaards. 1982. A simple and sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb. Haemostatis. 48:266-269.
45. Werb, Z., C. L. Mainardi, C. A. Vater, and E. D. Harris. 1977. Endogenous activation of collagenase by rheumatoid synovial cells. New Engl. J. Med. 296:1017-1023.
46. Wun, T.-C., L. Ossowski, and E. Reich. 1982. A proenzyme form of human urokinase. J. Biol. Chem. 257:7262-7268.
47. Yagel, S., A. H. Warner, H. N. Nellans, P. K. Lala, C. Waghorn, and D. T. Denhardt. 1989. Suppression by cathepsin L inhibitors of the invasion of amnion membrane by murine cancer cells. Cancer Res. 49:3553-3557.
48. Yu, H., and R. M. Schultz. 1990. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Cancer Res. 50:7623-7633.